Titre : Granulocytes

Granulocytes : Questions médicales fréquentes

Termes MeSH sélectionnés :

REM Sleep Behavior Disorder
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Granulocytes : Questions médicales les plus fréquentes", "headline": "Granulocytes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Granulocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-22", "dateModified": "2025-04-17", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Granulocytes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Leucocytes", "url": "https://questionsmedicales.fr/mesh/D007962", "about": { "@type": "MedicalCondition", "name": "Leucocytes", "code": { "@type": "MedicalCode", "code": "D007962", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Granulocytes basophiles", "alternateName": "Basophils", "url": "https://questionsmedicales.fr/mesh/D001491", "about": { "@type": "MedicalCondition", "name": "Granulocytes basophiles", "code": { "@type": "MedicalCode", "code": "D001491", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.315.120" } } }, { "@type": "MedicalWebPage", "name": "Granulocytes éosinophiles", "alternateName": "Eosinophils", "url": "https://questionsmedicales.fr/mesh/D004804", "about": { "@type": "MedicalCondition", "name": "Granulocytes éosinophiles", "code": { "@type": "MedicalCode", "code": "D004804", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.315.251" } } } ], "about": { "@type": "MedicalCondition", "name": "Granulocytes", "alternateName": "Granulocytes", "code": { "@type": "MedicalCode", "code": "D006098", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Cathy Conry-Cantilena", "url": "https://questionsmedicales.fr/author/Cathy%20Conry-Cantilena", "affiliation": { "@type": "Organization", "name": "Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD." } }, { "@type": "Person", "name": "Michael Gruber", "url": "https://questionsmedicales.fr/author/Michael%20Gruber", "affiliation": { "@type": "Organization", "name": "Department of Anesthesiology, University Hospital Regensburg, Raubling, Germany." } }, { "@type": "Person", "name": "Hans-Uwe Simon", "url": "https://questionsmedicales.fr/author/Hans-Uwe%20Simon", "affiliation": { "@type": "Organization", "name": "Institute of Pharmacology, University of Bern, Bern, Switzerland; email: thomas.kaufmann@pki.unibe.ch, hans-uwe.simon@pki.unibe.ch." } }, { "@type": "Person", "name": "Yu Hao", "url": "https://questionsmedicales.fr/author/Yu%20Hao", "affiliation": { "@type": "Organization", "name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China." } }, { "@type": "Person", "name": "Can Zhang", "url": "https://questionsmedicales.fr/author/Can%20Zhang", "affiliation": { "@type": "Organization", "name": "Biomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, China; Beijing Key Laboratory for Therapeutic Cancer Vaccines, Beijing 100038, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study.", "datePublished": "2024-10-25", "url": "https://questionsmedicales.fr/article/39454123", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1212/WNL.0000000000209993" } }, { "@type": "ScholarlyArticle", "name": "Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder.", "datePublished": "2023-06-25", "url": "https://questionsmedicales.fr/article/37393717", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2023.06.013" } }, { "@type": "ScholarlyArticle", "name": "Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder.", "datePublished": "2023-08-03", "url": "https://questionsmedicales.fr/article/37549588", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.parkreldis.2023.105794" } }, { "@type": "ScholarlyArticle", "name": "Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI.", "datePublished": "2022-09-03", "url": "https://questionsmedicales.fr/article/36116292", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2022.08.018" } }, { "@type": "ScholarlyArticle", "name": "Obstructive sleep apnea may reduce a diagnostic accuracy of video-polysomnography for idiopathic REM sleep behavior disorder.", "datePublished": "2022-11-19", "url": "https://questionsmedicales.fr/article/36470167", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.sleep.2022.11.018" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Leucocytes", "item": "https://questionsmedicales.fr/mesh/D007962" }, { "@type": "ListItem", "position": 5, "name": "Granulocytes", "item": "https://questionsmedicales.fr/mesh/D006098" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Granulocytes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Granulocytes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Granulocytes", "description": "Comment diagnostiquer une granulocytopénie ?\nQuels tests pour évaluer les granulocytes ?\nQuels signes indiquent une infection liée aux granulocytes ?\nComment évaluer la fonction des granulocytes ?\nQuel rôle joue la biopsie dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Granulocytes", "description": "Quels symptômes d'une carence en granulocytes ?\nComment se manifeste une réaction allergique ?\nQuels symptômes d'une inflammation ?\nQuels signes d'une infection bactérienne ?\nQuels symptômes d'une leucémie ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Granulocytes", "description": "Comment prévenir les infections chez les patients à faible granulocytes ?\nQuels vaccins sont recommandés ?\nComment éviter les complications liées aux granulocytes ?\nQuel rôle de l'alimentation dans la prévention ?\nComment gérer le stress pour la santé des granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Granulocytes", "description": "Comment traiter une granulocytopénie ?\nQuels médicaments stimulent les granulocytes ?\nComment traiter une infection liée aux granulocytes ?\nQuel rôle des corticostéroïdes dans le traitement ?\nQuand envisager une greffe de moelle osseuse ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Granulocytes", "description": "Quelles complications d'une granulocytopénie sévère ?\nQuels risques d'une leucémie myéloïde ?\nComment les granulocytes affectent-ils la cicatrisation ?\nQuelles sont les complications des traitements immunosuppresseurs ?\nQuels effets secondaires des médicaments sur les granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Granulocytes", "description": "Quels facteurs augmentent le risque d'infections ?\nQuel rôle des maladies auto-immunes ?\nComment le tabagisme affecte-t-il les granulocytes ?\nQuels risques liés à l'exposition aux produits chimiques ?\nQuel impact de la génétique sur les granulocytes ?", "url": "https://questionsmedicales.fr/mesh/D006098?mesh_terms=REM+Sleep+Behavior+Disorder&page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une granulocytopénie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un hémogramme révèle une diminution des granulocytes dans le sang." } }, { "@type": "Question", "name": "Quels tests pour évaluer les granulocytes ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins comme la numération formule sanguine sont utilisés." } }, { "@type": "Question", "name": "Quels signes indiquent une infection liée aux granulocytes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, fatigue et inflammation peuvent signaler une infection." } }, { "@type": "Question", "name": "Comment évaluer la fonction des granulocytes ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de phagocytose et de dégranulation peuvent être réalisés." } }, { "@type": "Question", "name": "Quel rôle joue la biopsie dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une biopsie médullaire peut aider à évaluer la production de granulocytes." } }, { "@type": "Question", "name": "Quels symptômes d'une carence en granulocytes ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Infections fréquentes, fièvre et fatigue sont des symptômes courants." } }, { "@type": "Question", "name": "Comment se manifeste une réaction allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Éruptions cutanées, démangeaisons et œdème peuvent survenir." } }, { "@type": "Question", "name": "Quels symptômes d'une inflammation ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, chaleur, gonflement et douleur sont des signes d'inflammation." } }, { "@type": "Question", "name": "Quels signes d'une infection bactérienne ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, frissons et douleur localisée peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels symptômes d'une leucémie ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, ecchymoses et infections fréquentes peuvent être présents." } }, { "@type": "Question", "name": "Comment prévenir les infections chez les patients à faible granulocytes ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hygiène et éviter les foules sont essentiels." } }, { "@type": "Question", "name": "Quels vaccins sont recommandés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre la grippe et le pneumocoque sont souvent conseillés." } }, { "@type": "Question", "name": "Comment éviter les complications liées aux granulocytes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Surveiller les signes d'infection et consulter rapidement un médecin." } }, { "@type": "Question", "name": "Quel rôle de l'alimentation dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée renforce le système immunitaire." } }, { "@type": "Question", "name": "Comment gérer le stress pour la santé des granulocytes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Des techniques de relaxation peuvent aider à réduire le stress." } }, { "@type": "Question", "name": "Comment traiter une granulocytopénie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Des transfusions de granulocytes ou des médicaments stimulants peuvent être utilisés." } }, { "@type": "Question", "name": "Quels médicaments stimulent les granulocytes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le filgrastim et le pegfilgrastim sont des agents couramment utilisés." } }, { "@type": "Question", "name": "Comment traiter une infection liée aux granulocytes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques sont prescrits pour traiter les infections bactériennes." } }, { "@type": "Question", "name": "Quel rôle des corticostéroïdes dans le traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent réduire l'inflammation et moduler la réponse immunitaire." } }, { "@type": "Question", "name": "Quand envisager une greffe de moelle osseuse ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "En cas de maladies graves affectant la production de granulocytes." } }, { "@type": "Question", "name": "Quelles complications d'une granulocytopénie sévère ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Infections graves, septicémie et complications hémorragiques peuvent survenir." } }, { "@type": "Question", "name": "Quels risques d'une leucémie myéloïde ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Risque accru d'infections et de saignements en raison de la production anormale." } }, { "@type": "Question", "name": "Comment les granulocytes affectent-ils la cicatrisation ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution des granulocytes peut retarder la cicatrisation des plaies." } }, { "@type": "Question", "name": "Quelles sont les complications des traitements immunosuppresseurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Infections opportunistes et cancers peuvent survenir avec ces traitements." } }, { "@type": "Question", "name": "Quels effets secondaires des médicaments sur les granulocytes ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent entraîner une diminution des granulocytes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'infections ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Une immunodépression, le diabète et l'âge avancé augmentent le risque." } }, { "@type": "Question", "name": "Quel rôle des maladies auto-immunes ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent entraîner une destruction accrue des granulocytes." } }, { "@type": "Question", "name": "Comment le tabagisme affecte-t-il les granulocytes ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme peut altérer la fonction des granulocytes et augmenter l'inflammation." } }, { "@type": "Question", "name": "Quels risques liés à l'exposition aux produits chimiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Certains produits chimiques peuvent endommager la moelle osseuse et réduire les granulocytes." } }, { "@type": "Question", "name": "Quel impact de la génétique sur les granulocytes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Des prédispositions génétiques peuvent influencer la production et la fonction des granulocytes." } } ] } ] }

Sources (10000 au total)

Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study.

Isolated REM sleep behavior disorder (iRBD) is strongly associated with synucleinopathies. Previous iRBD cohort studies have primarily focused on older (>50 years), male-predominant cohorts. Risk of p... One hundred eighty-six women and 186 men with iRBD were matched by polysomnography month. Baseline clinical variables and subsequent neurodegenerative outcomes were abstracted by chart review. Kaplan-... Age at iRBD diagnosis was younger in women compared with men (54.9 vs 62.5 years,... Age at diagnosis was independently associated with phenoconversion risk in women and men with iRBD....

Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder.

Degeneration of the nucleus basalis of Meynert (NBM) has been implicated in cognitive impairments in Parkinson's disease. The role of the NBM volumes in the cognitive function in isolated rapid eye mo... We investigated changes in NBM volumes and their associations with cognitive deficits in iRBD. Baseline NBM volumes were compared between 29 iRBD patients and 29 healthy controls by using structural M... Compared with controls, NBM volumes were significantly reduced in iRBD patients. In patients with iRBD, higher NBM volumes were significantly associated with greater performance in global cognition fu... This study provides important in vivo evidence for an association between the NBM degeneration and cognitive impairments in iRBD....

Diet quality and prodromal Parkinson's disease probability in isolated REM sleep behavior disorder.

It is reported that a diet that lowers oxidative stress reduces the prodromal Parkinson's disease (pPD) probability as well as the risk of Parkinson's disease (PD). In this study, we evaluated whether... Polysomnography (PSG)-confirmed iRBD patients from the Neurology Department at Seoul National University Hospital were enrolled. We calculated the pPD probability using the "Web-based Medical Calculat... We enrolled 101 patients with iRBD. The mean RFS score of patients with iRBD was 28.23 ± 9.29, which did not differ from the general population. Among patients with iRBD, the probability of pPD did no... Diet quality assessed by RFS did not differ between the general population and patients with iRBD in Korea. Further studies are needed to confirm these protective effects of legume consumption on iRBD...

Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI.

Mild cognitive impairment (MCI) is frequently diagnosed in patients with isolated rapid eye movement (REM) sleep behavior disorder (iRBD), although the extent of MCI-associated neuropathology has not ... Sixty-one patients with iRBD were included in the study: 30 patients were included in the MCI subgroup (RBD-MCI) and 31 in the normal cognition subgroup (RBD-NC). Both groups underwent neuropsychiatri... Neuropsychological measures generally confirmed overall cognitive decline in patients with iRBD-MCI. Immediate long-term verbal memory and visuospatial functions, as well as attentional-executive impa... This study confirmed that iRBD patients with MCI had a more impaired cognitive status that those with NC. Moreover, the MCI subgroup presented reduced cerebral glucose consumption in brain areas criti...

Obstructive sleep apnea may reduce a diagnostic accuracy of video-polysomnography for idiopathic REM sleep behavior disorder.

Severe obstructive sleep apnea (OSA) in patients with rapid eye movement (REM) sleep behavior disorder (RBD) may result in frequent fragmentation of REM sleep and consequently lead to a false negative... Patients with clinically diagnosed idiopathic RBD were included. RBD was confirmed if a video-PSG demonstrated complex motor behavior during REM sleep or REM sleep without atonia (RWA). Motor behavior... Of a total 254 patients included, a diagnosis of RBD was confirmed by a video-PSG in 221 patients (87.0%). RWA, vocalization, and axial or proximal muscle movements in REM sleep were noted in 86.6%, 5... OSA that requires CPAP may reduce a diagnostic accuracy for RBD by a video-PSG. False negative results were probably due to frequent electromyographic artifacts and/or severe sleep disruption from apn...

Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.

Previous studies revealed that sleep disorders are potential risk factors for cardiovascular diseases, such as obstructive sleep apnea and rapid eye movement (REM) sleep behavior disorder (RBD). Howev... We used the latest and largest summary-level genome-wide association studies of RBD, stroke and its subtypes, coronary artery disease (CAD), myocardial infarction (MI), and heart failure (HF) to selec... After multiple comparisons, genetically predicted RBD was significantly associated with the risk of HF [odds ratio (OR) = 1.033, 95% CI 1.013-1.052, p = 0.001]. Leave-one-out analysis further supporte... Our study highlighted the potential associations between RBD and cardiovascular diseases at genetic level, including HF and MI. More studies were required to clarify the biological mechanisms involved...

REM sleep behavior disorder correlates with constipation in de novo Chinese Parkinson's disease patients.

Constipation, rapid eye movement sleep behavior disorder (RBD) and hyposmia are common prodromal symptoms of Parkinson's disease (PD), and they may represent two distinct types of disease origin, from... A total of 111 de novo, drug-naïve Chinese PD patients were consecutively enrolled from Jan 2017 to Sept 2021. Patients were classified into PD with and without constipation based on item 5 of the Sca... In total, 44.1% (n = 49) of de novo PD patients had constipation. PD patients with constipation were older (p = 0.028), had higher proportions of Hoehn and Yahr (H-Y) stage [Formula: see text] 2 (p = ... RBD is closely associated with constipation in de novo Chinese PD patients. Our results support the theory that prodromal symptoms that represent the same pathological origin are closely related to ea...

Presence but not the timing of onset of REM sleep behavior disorder distinguishes evolution patterns in Parkinson's disease.

Rapid eye movement (REM) sleep behavior disorder (RBD) could develop preceding or come after motor symptoms during Parkinson's disease (PD). It remains unknown that whether PD with different timing of... We recruited 157 PD, 16 isolated RBD (iRBD), and 78 healthy controls. PD patients were identified as (1) PD with RBD preceding motor symptoms (PD-preRBD, n = 50), (2) PD with RBD posterior to motor sy... The model predicted that SN occupied the highest likelihood in the maximum likelihood sequence of disease progression in the all PD subgroups, while LC was specifically positioned earlier to SN in iRB... The spatiotemporal sequence of neurodegeneration between PD-pre and PD-post were similar but distinct from PD-nonRBD. The presence of RBD may be the essential factor for differentiating the degenerati...

Decreased serum BDNF contributes to the onset of REM sleep behavior disorder in Parkinson's disease patients.

Brain-derived neurotrophic factor (BDNF) promotes neuroprotection and neuroregeneration. BDNF enhances the survival of dopaminergic neurons and improves dopaminergic neurotransmission and motor perfor... We employed the Rapid Eye Movement Sleep Behavior Disorder Questionnaire-Hong Kong version (RBDQ-HK) and the Rapid Eye Movement Sleep Behavior Disorder Screening Questionnaire (RBDSQ) for RBD diagnosi... Our findings indicate that serum BDNF levels were significantly lower in PD patients compared to healthy controls (p < 0.001). PD-RBD patients exhibited higher motor symptom scores (UPDRS III) than PD... This study illustrates that decreased serum BDNF levels may be linked to the development of RBD in PD patients, highlighting the potential utility of BDNF as a biomarker in clinical practice....